NEW YORK (GenomeWeb News) — Cepheid today said first-quarter revenues increased 27 percent as R&D spending rose 19 percent and profit declined around 6 percent.
 
Total receipts for the three months ended March 31 increased to $25.5 million from $20.1 million year over year.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.